van der Heijde, D., Gensler, L. S., Deodhar, A., Baraliakos, X., Poddubnyy, D., Kivitz, A., . . . Dougados, M. (2020). Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: Results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis.
Citación estilo Chicagovan der Heijde, Désirée, et al. "Dual Neutralisation of Interleukin-17A and Interleukin-17F With Bimekizumab in Patients With Active Ankylosing Spondylitis: Results From a 48-week Phase IIb, Randomised, Double-blind, Placebo-controlled, Dose-ranging Study." Ann Rheum Dis 2020.
Cita MLAvan der Heijde, Désirée, et al. "Dual Neutralisation of Interleukin-17A and Interleukin-17F With Bimekizumab in Patients With Active Ankylosing Spondylitis: Results From a 48-week Phase IIb, Randomised, Double-blind, Placebo-controlled, Dose-ranging Study." Ann Rheum Dis 2020.